OMNILINK ELITE PERIPHERAL BALLOON-EXPANDABLE STENT SYSTEM

FDA Premarket Approval P110043

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the omnilink elite vascular balloon-expandable stent system. This device is indicated for the treatment of atherosclerotic iliac artery lesions with reference vessel diameters of >= 5. 0 mm and

DeviceOMNILINK ELITE PERIPHERAL BALLOON-EXPANDABLE STENT SYSTEM
Generic NameStent, Iliac
ApplicantABBOTT VASCULAR-CARDIAC THERAPIES
Date Received2011-12-30
Decision Date2012-07-31
Notice Date2012-08-03
PMAP110043
SupplementS
Product CodeNIO 
Docket Number12M-0833
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT VASCULAR-CARDIAC THERAPIES 3200 Lakeside Dr. santa Clara, CA 95054-2807
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P110043Original Filing
S013 2022-08-09 30-day Notice
S012 2020-08-14 30-day Notice
S011 2016-08-19 30-day Notice
S010 2016-04-29 30-day Notice
S009 2014-09-02 30-day Notice
S008 2014-08-27 30-day Notice
S007 2014-08-08 30-day Notice
S006 2014-04-14 30-day Notice
S005
S004 2013-11-08 30-day Notice
S003 2012-10-01 Normal 180 Day Track No User Fee
S002 2012-08-27 30-day Notice
S001 2012-08-24 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.